A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 11 EUR Market Closed
Market Cap: €93.5m

Profitability Summary

Apontis Pharma AG's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Apontis Pharma AG

Margins Comparison
Apontis Pharma AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Apontis Pharma AG
XETRA:APPH
91.6m EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
440.4B EUR
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Apontis Pharma AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Apontis Pharma AG
XETRA:APPH
91.6m EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
440.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Apontis Pharma AG

Last Value
3-Years Average
FCF Margin
Conversion Rate